one hundred seventeen postmenopausal advanced breast cancer patients previously untreated with chemotherapy were randomized to receive : cyclophosphamide , methotrexate , and 5-fluorouracil ( cmf ) , cmf and tamoxifen ( tmx ) , and cmf and medroxyprogesterone ( map ) .
C0025677
methotrexate
C0950521
cmf